During the past decade, Grace Nursing Home conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grace Nursing Home" #1 collaborator was "Merck Ltd., India" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Grace Nursing Home" are "Carcinoma, Squamous Cell" (1 trials) and "Colorectal Neoplasms" (1 trials). Many other conditions were trialed in "Grace Nursing Home" in a lesser frequency.

Most popular intervention types in "Grace Nursing Home" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cetuximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Grace Nursing Home" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Grace Nursing Home". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Grace Nursing Home, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Grace Nursing Home, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".